Medicus Sciences Acquisition Corp. Class A (MSAC)
$10.17
$0.00 (0.00%)As on 24-Feb-2023 09:30EDT
Market cap
$118 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
31.8
P/B Ratio
1.3
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$6 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-165.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$1126290.3
-
Face value
--
-
Shares outstanding
9,292,000
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medicus Sciencescquisition Corp. Class A (MSAC)
| 1.0 | 0.7 | 2.0 | 4.6 | -- | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
Company
|
2022
|
|---|---|
|
Medicus Sciencescquisition Corp. Class A (MSAC)
| 3.6 |
|
BSE Sensex
| 4.4 |
|
BSE Sensex
| 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Medicus Sciencescquisition Corp. Class A (MSAC)
|
10.2 | 118.1 | 0.0 | 2,252,580.7 | -- | -- | 31.8 | 1.3 |
| 10.1 | 295.6 | 0.0 | -7.4 | -- | -- | -- | 4.2 |
Shareholding Pattern
View DetailsAbout Medicus Sciencescquisition Corp. Class A (MSAC)
Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.... It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally. The company was incorporated in 2020 and is based in New York, New York. Read more
-
Exec. Chairman
Dr. Jacob Jay Gottlieb C.F.A., CFA, M.D.
-
Exec. Chairman
Dr. Jacob Jay Gottlieb C.F.A., CFA, M.D.
-
Headquarters
New York, NY
-
Website
FAQs for Medicus Sciencescquisition Corp. Class A (MSAC)
What is the current share price of Medicus Sciences Acquisition Corp Class A (MSAC) Today?
The share price of Medicus Sciences Acquisition Corp Class A (MSAC) is $10.17 (NASDAQ) as of 24-Feb-2023 09:30 EDT. Medicus Sciences Acquisition Corp Class A (MSAC) has given a return of 4.63% in the last 1 years.
What is the current PB & PE ratio of Medicus Sciences Acquisition Corp Class A (MSAC)?
The P/E ratio of Medicus Sciences Acquisition Corp Class A (MSAC) is 31.78 times as on 10-Mar-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
10.24 |
-2,926.39 |
2020 |
-- |
-- |
2021 |
10.24 |
-2,926.39 |
2020 |
-- |
-- |
What is the 52 Week High and Low of Medicus Sciences Acquisition Corp Class A (MSAC)?
The 52-week high and low of Medicus Sciences Acquisition Corp Class A (MSAC) are Rs -- and Rs -- as of 29-Aug-2026.
What is the market cap of Medicus Sciences Acquisition Corp Class A (MSAC)?
Medicus Sciences Acquisition Corp Class A (MSAC) has a market capitalisation of $ 118 Mln as on 10-Mar-2023. As per SEBI classification, it is a company.
Should I invest in Medicus Sciences Acquisition Corp Class A (MSAC)?
Before investing in Medicus Sciences Acquisition Corp Class A (MSAC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.